232 related articles for article (PubMed ID: 17178894)
1. Diverse gene expression and DNA methylation profiles correlate with differential adaptation of breast cancer cells to the antiestrogens tamoxifen and fulvestrant.
Fan M; Yan PS; Hartman-Frey C; Chen L; Paik H; Oyer SL; Salisbury JD; Cheng AS; Li L; Abbosh PH; Huang TH; Nephew KP
Cancer Res; 2006 Dec; 66(24):11954-66. PubMed ID: 17178894
[TBL] [Abstract][Full Text] [Related]
2. Aurora kinase B is important for antiestrogen resistant cell growth and a potential biomarker for tamoxifen resistant breast cancer.
Larsen SL; Yde CW; Laenkholm AV; Rasmussen BB; Duun-Henriksen AK; Bak M; Lykkesfeldt AE; Kirkegaard T
BMC Cancer; 2015 Apr; 15():239. PubMed ID: 25885472
[TBL] [Abstract][Full Text] [Related]
3. A suppressive role of guanine nucleotide-binding protein subunit beta-4 inhibited by DNA methylation in the growth of anti-estrogen resistant breast cancer cells.
Wang B; Li D; Rodriguez-Juarez R; Farfus A; Storozynsky Q; Malach M; Carpenter E; Filkowski J; Lykkesfeldt AE; Kovalchuk O
BMC Cancer; 2018 Aug; 18(1):817. PubMed ID: 30103729
[TBL] [Abstract][Full Text] [Related]
4. ER-α variant ER-α36 mediates antiestrogen resistance in ER-positive breast cancer stem/progenitor cells.
Deng H; Yin L; Zhang XT; Liu LJ; Wang ML; Wang ZY
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt B():417-26. PubMed ID: 25158023
[TBL] [Abstract][Full Text] [Related]
5. Stabilization of MORC2 by estrogen and antiestrogens through GPER1- PRKACA-CMA pathway contributes to estrogen-induced proliferation and endocrine resistance of breast cancer cells.
Yang F; Xie HY; Yang LF; Zhang L; Zhang FL; Liu HY; Li DQ; Shao ZM
Autophagy; 2020 Jun; 16(6):1061-1076. PubMed ID: 32401166
[TBL] [Abstract][Full Text] [Related]
6. Antiestrogen Resistant Cell Lines Expressing Estrogen Receptor α Mutations Upregulate the Unfolded Protein Response and are Killed by BHPI.
Mao C; Livezey M; Kim JE; Shapiro DJ
Sci Rep; 2016 Oct; 6():34753. PubMed ID: 27713477
[TBL] [Abstract][Full Text] [Related]
7. Reprogramming of the ERRα and ERα target gene landscape triggers tamoxifen resistance in breast cancer.
Thewes V; Simon R; Schroeter P; Schlotter M; Anzeneder T; Büttner R; Benes V; Sauter G; Burwinkel B; Nicholson RI; Sinn HP; Schneeweiss A; Deuschle U; Zapatka M; Heck S; Lichter P
Cancer Res; 2015 Feb; 75(4):720-31. PubMed ID: 25643697
[TBL] [Abstract][Full Text] [Related]
8. Differential microRNA profiles between fulvestrant-resistant and tamoxifen-resistant human breast cancer cells.
Zhou Q; Zeng H; Ye P; Shi Y; Guo J; Long X
Anticancer Drugs; 2018 Jul; 29(6):539-548. PubMed ID: 29557813
[TBL] [Abstract][Full Text] [Related]
9. Integrative analyses of gene expression and DNA methylation profiles in breast cancer cell line models of tamoxifen-resistance indicate a potential role of cells with stem-like properties.
Lin X; Li J; Yin G; Zhao Q; Elias D; Lykkesfeldt AE; Stenvang J; Brünner N; Wang J; Yang H; Bolund L; Ditzel HJ
Breast Cancer Res; 2013 Dec; 15(6):R119. PubMed ID: 24355041
[TBL] [Abstract][Full Text] [Related]
10. Different epigenetic mechanisms of ERα implicated in the fate of fulvestrant-resistant breast cancer.
Tsuboi K; Kaneko Y; Nagatomo T; Fujii R; Hanamura T; Gohno T; Yamaguchi Y; Niwa T; Hayashi SI
J Steroid Biochem Mol Biol; 2017 Mar; 167():115-125. PubMed ID: 27888136
[TBL] [Abstract][Full Text] [Related]
11. Breast Cancer Resistance to Antiestrogens Is Enhanced by Increased ER Degradation and ERBB2 Expression.
Shibata T; Watari K; Izumi H; Kawahara A; Hattori S; Fukumitsu C; Murakami Y; Takahashi R; Toh U; Ito KI; Ohdo S; Tanaka M; Kage M; Kuwano M; Ono M
Cancer Res; 2017 Jan; 77(2):545-556. PubMed ID: 27879270
[TBL] [Abstract][Full Text] [Related]
12. Identification of Antiestrogen-Bound Estrogen Receptor α Interactomes in Hormone-Responsive Human Breast Cancer Cell Nuclei.
Gigantino V; Salvati A; Giurato G; Palumbo D; Strianese O; Rizzo F; Tarallo R; Nyman TA; Weisz A; Nassa G
Proteomics; 2020 Oct; 20(19-20):e2000135. PubMed ID: 32865868
[TBL] [Abstract][Full Text] [Related]
13. Combination treatment with proteasome inhibitors and antiestrogens has a synergistic effect mediated by p21WAF1 in estrogen receptor-positive breast cancer.
Maynadier M; Basile I; Gallud A; Gary-Bobo M; Garcia M
Oncol Rep; 2016 Aug; 36(2):1127-34. PubMed ID: 27373750
[TBL] [Abstract][Full Text] [Related]
14. High-density array analysis of DNA methylation in Tamoxifen-resistant breast cancer cell lines.
Williams KE; Anderton DL; Lee MP; Pentecost BT; Arcaro KF
Epigenetics; 2014 Feb; 9(2):297-307. PubMed ID: 24225485
[TBL] [Abstract][Full Text] [Related]
15. The neuropeptide y y(1) receptor: a diagnostic marker? Expression in mcf-7 breast cancer cells is down-regulated by antiestrogens in vitro and in xenografts.
Memminger M; Keller M; Lopuch M; Pop N; Bernhardt G; von Angerer E; Buschauer A
PLoS One; 2012; 7(12):e51032. PubMed ID: 23236424
[TBL] [Abstract][Full Text] [Related]
16. ZEB1 induces ER-α promoter hypermethylation and confers antiestrogen resistance in breast cancer.
Zhang J; Zhou C; Jiang H; Liang L; Shi W; Zhang Q; Sun P; Xiang R; Wang Y; Yang S
Cell Death Dis; 2017 Apr; 8(4):e2732. PubMed ID: 28383555
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of estrogen receptor-α induces autophagy and inhibits antiestrogen-mediated unfolded protein response activation, promoting ROS-induced breast cancer cell death.
Cook KL; Clarke PA; Parmar J; Hu R; Schwartz-Roberts JL; Abu-Asab M; Wärri A; Baumann WT; Clarke R
FASEB J; 2014 Sep; 28(9):3891-905. PubMed ID: 24858277
[TBL] [Abstract][Full Text] [Related]
18. Calcitriol restores antiestrogen responsiveness in estrogen receptor negative breast cancer cells: a potential new therapeutic approach.
Santos-Martínez N; Díaz L; Ordaz-Rosado D; García-Quiroz J; Barrera D; Avila E; Halhali A; Medina-Franco H; Ibarra-Sánchez MJ; Esparza-López J; Camacho J; Larrea F; García-Becerra R
BMC Cancer; 2014 Mar; 14():230. PubMed ID: 24678876
[TBL] [Abstract][Full Text] [Related]
19. IGFBP-3 sensitizes antiestrogen-resistant breast cancer cells through interaction with GRP78.
Li C; Harada A; Oh Y
Cancer Lett; 2012 Dec; 325(2):200-6. PubMed ID: 22801219
[TBL] [Abstract][Full Text] [Related]
20. Role of SUMOylation in differential ERα transcriptional repression by tamoxifen and fulvestrant in breast cancer cells.
Traboulsi T; El Ezzy M; Dumeaux V; Audemard E; Mader S
Oncogene; 2019 Feb; 38(7):1019-1037. PubMed ID: 30190545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
